Chairman
Merck & Co., Inc. (MRK)Board Member
Merck & Co., Inc. (MRK)Equibles does not estimate personal net worth.
Get an email with a short summary when Merck & Co., Inc. publishes a filing, an earnings call transcript or a press release.
Get MRK alertsRobert M. Davis is recorded as Chairman at Merck & Co., Inc. (MRK) since December 1, 2022 and CEO and Board Member at Merck & Co., Inc. (MRK) since July 1, 2021. Merck & Co., Inc. reported in an 8-K filed October 27, 2022 that Robert M. Davis was appointed Chairman of the Board, effective December 1, 2022. The proxy statement of Merck & Co., Inc. reports total compensation of $20,797,845 for Robert M. Davis in fiscal 2025, including a base salary of $1,645,302. Disclosed compensation is on record for 9 fiscal years. Robert M. Davis has spoken on 2 investor events across 1 company, most recently for Merck & Co., Inc. on September 14, 2026. Merck & Co., Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Merck & Co., Inc. includes Jennifer Zachary (General Counsel), Dalton E. Smart III (Chief Accounting Officer), Christine E. Seidman (Board Member) and 7 others.
“In addition, on October 26, 2022, the Board unanimously elected Robert M. Davis, Merck's current Chief Executive Officer and President as well as a Director on the Board to serve as Chairman of the Board, effective December 1, 2022.”
“I mean, obviously, already, 2026 has been a very eventful year for us.”
“I'm pleased to welcome you to our 2026 Annual Meeting of Shareholders and to call this meeting to order. This marks my fifth annual meeting as Chief Executive Officer, and I'm honored to be with you today to speak about our company and our progress.”
2022-12-01–present
2021-07-01–present
2021-07-01–present
SEC 8-K
2021-04-01–present
Drug Manufacturers - General · Healthcare
Chairman, CEO, Board Member
2021-04-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Merck & Co., Inc. (MRK) | Chairman, Chief Executive Officer and President | $1,645,302 | $20,797,845 |
| 2024 | Merck & Co., Inc. (MRK) | Chairman, Chief Executive Officer and President | $1,623,874 | $23,186,064 |
| 2023 | Merck & Co., Inc. (MRK) | Chairman, Chief Executive Officer and President | $1,603,091 | $20,273,287 |
| 2022 | Merck & Co., Inc. (MRK) | Chairman, Chief Executive Officer and President | $1,538,613 | $18,650,093 |
| 2021 | Merck & Co., Inc. (MRK) | Chairman, Chief Executive Officer and President | $1,319,959 | $13,722,121 |
| 2020 | Merck & Co., Inc. (MRK) | Chairman, Chief Executive Officer and President | $1,112,795 | $6,839,510 |
| 2019 | Merck & Co., Inc. (MRK) | Chief Executive Officer, President and Former Chief Financial Officer | $1,075,557 | $7,727,188 |
| 2018 | Merck & Co., Inc. (MRK) | President and Former Chief Financial Officer | $1,043,726 | $6,620,840 |
| 2017 | Merck & Co., Inc. (MRK) | Executive Vice President, Global Services and Chief Financial Officer | $1,018,269 | $6,310,899 |
